| NDC Code | 0703-5854-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-5854-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 0703-5854 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Fludarabine Phosphate |
|---|
| Non-Proprietary Name | Fludarabine Phosphate |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20030912 |
|---|
| End Marketing Date | 20181231 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA076349 |
|---|
| Manufacturer | Teva Parenteral Medicines, Inc. |
|---|
| Substance Name | FLUDARABINE PHOSPHATE |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/2mL |
|---|
| Pharmacy Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
|---|